1. Home
  2. SMID vs STTK Comparison

SMID vs STTK Comparison

Compare SMID & STTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SMID
  • STTK
  • Stock Information
  • Founded
  • SMID 1960
  • STTK 2016
  • Country
  • SMID United States
  • STTK United States
  • Employees
  • SMID N/A
  • STTK N/A
  • Industry
  • SMID Building Materials
  • STTK Biotechnology: Pharmaceutical Preparations
  • Sector
  • SMID Industrials
  • STTK Health Care
  • Exchange
  • SMID Nasdaq
  • STTK Nasdaq
  • Market Cap
  • SMID 157.4M
  • STTK 37.6M
  • IPO Year
  • SMID 1995
  • STTK 2020
  • Fundamental
  • Price
  • SMID $37.91
  • STTK $0.83
  • Analyst Decision
  • SMID
  • STTK Hold
  • Analyst Count
  • SMID 0
  • STTK 4
  • Target Price
  • SMID N/A
  • STTK $3.00
  • AVG Volume (30 Days)
  • SMID 20.4K
  • STTK 423.3K
  • Earning Date
  • SMID 07-10-2025
  • STTK 07-31-2025
  • Dividend Yield
  • SMID N/A
  • STTK N/A
  • EPS Growth
  • SMID 444.88
  • STTK N/A
  • EPS
  • SMID 1.86
  • STTK N/A
  • Revenue
  • SMID $84,450,000.00
  • STTK $4,606,000.00
  • Revenue This Year
  • SMID N/A
  • STTK N/A
  • Revenue Next Year
  • SMID N/A
  • STTK N/A
  • P/E Ratio
  • SMID $19.14
  • STTK N/A
  • Revenue Growth
  • SMID 33.01
  • STTK 69.65
  • 52 Week Low
  • SMID $25.13
  • STTK $0.69
  • 52 Week High
  • SMID $51.96
  • STTK $4.99
  • Technical
  • Relative Strength Index (RSI)
  • SMID 71.21
  • STTK 38.86
  • Support Level
  • SMID $32.85
  • STTK $0.75
  • Resistance Level
  • SMID $35.37
  • STTK $0.85
  • Average True Range (ATR)
  • SMID 1.63
  • STTK 0.09
  • MACD
  • SMID 0.51
  • STTK -0.01
  • Stochastic Oscillator
  • SMID 82.07
  • STTK 9.59

About SMID Smith-Midland Corporation

Smith-Midland Corp through its subsidiaries invents, develops, manufactures, markets, sells, and installs precast concrete products for primary use in the construction, highway, utilities, and farming industries. The firm's customers are general contractors and federal, state, and local transportation authorities. Its products include Slenderwall, JJhooks, Softsound, Sierra Wall and Easi set. A substantial portion of the company's business is derived from local, state, and federal building projects. The company generates revenues predominantly from the sale, leasing, licensing, shipping, and installation of precast concrete products for the construction, utility, and farming industries.

About STTK Shattuck Labs Inc.

Shattuck Labs Inc is a biotechnology company specializing in the development of potential treatments for inflammatory and immune-mediated diseases. It is developing a potentially first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. The company's expertise in protein engineering and the development of novel tumor necrosis factor (TNF) receptor therapeutics comes together in its main program, SL-325, which has the potential to be a first-in-class death receptor 3 (DR3) antagonist antibody. In addition, the company is developing SL-425, a half-life extended version of SL-325, and multiple other preclinical DR3-based bispecific antibodies, for the treatment of patients with IBD.

Share on Social Networks: